The vesicular monoamine transporter (VMAT) is a transport protein integrated into the membranes of synaptic vesicles of presynaptic neurons. It transports... 43 KB (4,993 words) - 22:10, 12 March 2024 |
 | solute carrier family 18 member 2 (SLC18A2) also known as vesicular monoamine transporter 2 (VMAT2) is a protein that in humans is encoded by the SLC18A2... 17 KB (2,015 words) - 05:34, 27 November 2023 |
 | Vesicular monoamine transporter 1 (VMAT1) also known as chromaffin granule amine transporter (CGAT) or solute carrier family 18 member 1 (SLC18A1) is a... 16 KB (1,962 words) - 22:11, 12 March 2024 |
 | Monoamine transporters (MATs) are proteins that function as integral plasma-membrane transporters to regulate concentrations of extracellular monoamine... 21 KB (2,340 words) - 07:25, 29 December 2023 |
 | serotonin transporter (SERT), and the norepinephrine transporter (NET) in the outer cell membrane and the vesicular monoamine transporter (VMAT1 and... 7 KB (1,409 words) - 21:17, 11 March 2024 |
 | Reuptake inhibitor (redirect from Vesicular transporter blocker) hemicholinium-3, triethylcholine Vesicular acetylcholine transporter (VAChT) inhibitor – vesamicol Vesicular monoamine transporter (VMAT) inhibitor – reserpine... 19 KB (1,909 words) - 02:26, 28 March 2024 |
 | For example, certain proteins such as the dopamine transporter (DAT), vesicular monoamine transporter 2 (VMAT2), and dopamine receptors can be classified... 11 KB (1,161 words) - 23:59, 2 May 2024 |
 | amine-associated receptor 1 (TAAR1) and inhibiting vesicular monoamine transporter 2 (VMAT2) in monoamine neurons. To a lesser extent, it also acts as a neurotransmitter... 42 KB (4,237 words) - 17:04, 11 March 2024 |
 | that in humans is encoded by the SLC6A4 gene. SERT is a type of monoamine transporter protein that transports the neurotransmitter serotonin from the... 30 KB (3,578 words) - 00:39, 27 December 2023 |
 | neuron, they may inhibit the reuptake of monoamine neurotransmitters through vesicular monoamine transporter 2 (VMAT2) and release the neurotransmitters... 37 KB (2,323 words) - 21:25, 11 March 2024 |
 | Valbenazine (category Monoamine-depleting agents) medication used to treat tardive dyskinesia. It acts as a vesicular monoamine transporter 2 (VMAT2) inhibitor. Valbenazine is used to treat tardive dyskinesia... 12 KB (879 words) - 02:44, 9 March 2024 |
Serotonin transporter (SERT) Vesicular monoamine transporter 1 (VMAT1) Vesicular monoamine transporter 2 (VMAT2) Adenosine transporters, including: Equilibrative... 9 KB (988 words) - 00:34, 19 August 2023 |
 | with human trace amine-associated receptor 1 (hTAAR1) and vesicular monoamine transporter 2 (VMAT2) in neurons. Dextroamphetamine is a more potent Central... 56 KB (19,815 words) - 16:38, 1 May 2024 |
is influenced by heredity and that a specific gene, called vesicular monoamine transporter 2 (VMAT2), predisposes humans towards spiritual or mystic experiences... 9 KB (1,046 words) - 11:06, 4 April 2024 |
Membrane transport protein (redirect from Membrane transporter) Dopamine transporter (DAT) Norepinephrine transporter (NET) Serotonin transporter (SERT) Vesicular monoamine transporters (VMAT) Adenine nucleotide translocator... 25 KB (2,649 words) - 12:33, 13 March 2024 |
 | human dopamine neurons, as both compounds induce efflux from vesicular monoamine transporter 2 (VMAT2) and activate TAAR1 with comparable efficacy. Like... 19 KB (2,166 words) - 18:35, 24 August 2023 |
 | by the solute carrier family 6 member 2 (SLC6A2) gene. NET is a monoamine transporter and is responsible for the sodium-chloride (Na+/Cl−)-dependent reuptake... 31 KB (3,397 words) - 02:14, 21 December 2023 |
 | attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum". The Journal of... 13 KB (1,249 words) - 17:42, 18 April 2024 |
 | Deutetrabenazine (category Monoamine-depleting agents) Deutetrabenazine (trade name Austedo) is a vesicular monoamine transporter 2 inhibitor which is used for the treatment of chorea associated with Huntington's... 9 KB (652 words) - 03:24, 22 January 2024 |
| widely accepted model for monoamine transporter function, sodium ions must bind to the extracellular domain of the transporter before dopamine can bind... 37 KB (4,635 words) - 06:51, 29 March 2024 |
 | dopamine transporter or by the plasma membrane monoamine transporter. Once back in the cytosol, dopamine can either be broken down by a monoamine oxidase... 138 KB (14,160 words) - 01:01, 30 April 2024 |
 | Glucose transporters are a wide group of membrane proteins that facilitate the transport of glucose across the plasma membrane, a process known as facilitated... 16 KB (1,327 words) - 10:35, 15 February 2024 |
medications are used to treat tardive dyskinesia. These include the vesicular monoamine transporter 2 inhibitors tetrabenazine and deutetrabenazine. Extrapyramidal... 13 KB (1,359 words) - 06:00, 24 March 2024 |
Reverse transport (redirect from Transporter reversal) the synaptic cleft via monoamine transporter-mediated release) by triggering reverse transport at vesicular monoamine transporters (specifically, VMAT1... 7 KB (584 words) - 01:21, 7 December 2020 |
glutamate transporters is composed of two primary subclasses: the excitatory amino acid transporter (EAAT) family and vesicular glutamate transporter (VGLUT)... 24 KB (2,828 words) - 15:14, 24 September 2023 |
 | The plasma membrane monoamine transporter (PMAT) is a low-affinity monoamine transporter protein which in humans is encoded by the SLC29A4 gene. It is... 13 KB (1,447 words) - 22:59, 9 March 2024 |
 | SLC22A3 (redirect from Extraneuronal monoamine transporter) 3 (SLC22A3) also known as the organic cation transporter 3 (OCT3) or extraneuronal monoamine transporter (EMT) is a protein that in humans is encoded... 11 KB (1,306 words) - 14:13, 12 March 2024 |
Dysdiadochokinesia has been linked to a mutation in SLC18A2, which encodes vesicular monoamine transporter 2 (VMAT2). "dysdiadochokinesia". Farlex Partner Medical Dictionary... 5 KB (522 words) - 17:16, 11 February 2024 |
 | "Novel N-1,2-dihydroxypropyl analogs of lobelane inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release". Journal... 15 KB (1,259 words) - 12:05, 29 March 2024 |
 | Vesicular inhibitory amino acid transporter is a protein that in humans is encoded by the SLC32A1 gene. The protein encoded by this gene is an integral... 4 KB (452 words) - 07:03, 15 January 2024 |